Skip to main content
. 2025 Jul 21;45(5):441–453. doi: 10.1097/JCP.0000000000002047

TABLE 4.

Summary of RE104 Plasma PK Parameters by Dose (PK Evaluable Population)

Plasma PK Parameters RE104 Dose
5 mg (n=6) 11 mg (n=6) 20 mg (n=6) 30 mg (n=9) 35 mg (n=6) 40 mg (n=3)
Summary Statistics
Cmax (ng/mL) 149.756 (63.0) 491.960 (43.8) 779.898 (15.9) 1319.347 (47.2) 1224.425 (20.1) 1781.941 (19.9)
Tmax (h) 0.500 (0.25-0.50) 0.250 (0.25-0.50) 0.375 (0.25-0.50) 0.250 (0.12-0.50) 0.375 (0.25-0.50) 0.500 (0.25-0.50)
Tlast (h) 4.000 (3.00-5.00) 5.000 (4.00-6.00) 5.000 (4.00-6.02) 5.000 (4.00-5.15) 5.542 (4.00-8.00) 6.183 (6.02-8.00)
Tlag (h) 0 0 0 0 0 0
kel (1/h) 1.391 (0.39340) 1.485 (0.29261) 1.459 (0.40487) 1.641 (0.21051) 1.248 (0.53208) 1.329 (0.15708)
t½ (h) 0.5315 (0.14595) 0.4829 (0.10037) 0.5046 (0.12989) 0.4293 (0.061541) 0.6437 (0.25484) 0.5265 (0.063774)
AUC0-t (h*ng/mL) 134.8 (64.9) 433.2 (49.4) 764.6 (16.7) 978.2 (27.6) 1187 (15.4) 1814 (15.8)
AUC0-inf (h*ng/mL) 135.6 (64.6) 433.6 (49.3) 765.3 (16.7) 978.8 (27.6) 1188 (15.5) 1814 (15.8)
%AUCext (%) 0.6066 (0.40628) 0.1050 (0.036846) 0.08935 (0.039773) 0.06384 (0.026512) 0.08987 (0.095418) 0.03467 (0.019110)
Cmax/dose (ng/mL/mg) 29.951 (63.0) 49.196 (43.8) 38.995 (15.9) 43.978 (47.2) 35.439 (20.1) 44.549 (19.9)
AUC0-t/dose (h*ng/mL/mg) 26.96 (64.9) 43.32 (49.4) 38.23 (16.7) 32.61 (27.6) 34.34 (15.4) 45.35 (15.8)
AUC0-inf/dose (h*ng/mL/mg) 27.13 (64.6) 43.36 (49.3) 38.26 (16.7) 32.63 (27.6) 34.37 (15.5) 45.36 (15.8)
CL/F (L/h) 41.76 (20.132) 25.22 (11.553) 26.42 (3.9805) 31.69 (8.9501) 29.37 (4.3424) 22.22 (3.3857)
Vz/F (L) 31.75 (19.195) 16.58 (5.4335) 19.36 (6.3849) 19.93 (7.3932) 26.60 (9.6718); 6 16.67 (0.65750); 3

AUCs, Cmax, and their dose-normalized transformations are presented as geometric mean (geometric CV%); n=number of observations.

Tmax, Tlast, and Tlag are presented as median (min-max); n=number of observations.